Back in June 2024, I argued that the $2.54 billion Street consensus for 2025 was very conservative, and I saw a strong setup for strong sales momentum driven by the CIDP launch and that this year ...

No-moat Revolve Group posted strong fourth-quarter earnings, with sales growth accelerating to 14% (from 10% a quarter earlier) as marketing investments and new categories build momentum.

Fever-Tree saw its sales recover in the second half of last year as it sought to regain momentum after a soggy first half. Total revenue rose 4% to £364m on a constant currency basis, following a ...

According to traders, Eid sales usually pick up after the second week of Ramadan, and this year is no exception. Bipani Bitan ...

Cytokine fusion proteins, such as ANKTIVA, represent a novel class of biologics that improve immune responses by enhancing the therapeutic potential of cytokines and promoting lymphocyte ...